#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13692	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2236	610.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1472	1472	C	831	C,T	766,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13692	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2236	610.2	0	HET	.	.	.	G570A	.	570	570	G	858	858	G	761	G,A	577,134	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13692	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2236	610.2	0	HET	.	.	.	C207T	.	207	207	C	495	495	C	732	C,T	554,120	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25164	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3638	689.8	0	.	n	.	0	T695C	SNP	695	695	T	1072	1072	C	763	C	706	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25164	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3638	689.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	2015	2015	G	845	G	789	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25164	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3638	689.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2348	2348	C	852	C	786	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25164	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3638	689.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2422	2422	A	831	A,G	779,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25164	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3638	689.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2974	2974	C	783	C	734	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1722	folP	855	855	100.0	folP.l15.c30.ctg.1	1603	107.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1115	1117	AGC	201;201;198	A;G,C;C	188;185,1;183	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4324	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3421	126.0	1	SNP	p	S91F	1	.	.	271	273	TTC	635	637	TTC	169;167;165	T;T;C	154;152;153	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4324	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3421	126.0	1	SNP	p	D95G	1	.	.	283	285	GGC	647	649	GGC	158;160;160	G;G;C	145;149;146	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4324	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3421	126.0	1	SNP	p	G95N	0	.	.	283	285	GGC	647	649	GGC	158;160;160	G;G;C	145;149;146	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1370	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1385	98.3	1	SNP	p	G45D	0	.	.	133	135	GGC	501	503	GGC	164;164;165	G;G;C	155;155;154	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	724	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1008	71.6	0	.	n	.	0	A197.	DEL	197	197	A	601	601	A	177	A	166	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2967	184.2	1	SNP	p	D86N	0	.	.	256	258	GAC	615	617	GAC	221;218;222	G;A;C	213;207;212	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2967	184.2	1	SNP	p	R87W	0	.	.	259	261	CGT	618	620	CGT	224;221;222	C;G;T	213;207;208	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2967	184.2	1	SNP	p	S87R	1	.	.	259	261	CGT	618	620	CGT	224;221;222	C;G;T	213;207;208	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2967	184.2	1	SNP	p	R87I	0	.	.	259	261	CGT	618	620	CGT	224;221;222	C;G;T	213;207;208	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5486	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2967	184.2	1	SNP	p	S88P	0	.	.	262	264	TCC	621	623	TCC	223;225;225	T,G;C;C	210,1;213;214	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3384	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2583	130.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1480	1482	GGC	163;159;157	G;G;C	155;151;148	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1302	1304	GCC	169;169;169	G;C,A;C	161;161,1;161	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1305	1307	ATG	170;170;169	A;T;G,A	163;163;161,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1317	1319	ACC	172;172;170	A;C;C	161;161;160	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1317	1319	ACC	172;172;170	A;C;C	161;161;160	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1818	1820	ACC	207;206;203	A;C;C	183;185;187	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1872	1874	GCG	190;190;191	G;C;G	175;175;175	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1872	1874	GCG	190;190;191	G;C;G	175;175;175	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1995	1997	GGT	164;166;167	G;G;T	152;153;152	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2004	2006	AGC	165;168;167	A;G;C	148;149;147	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2498	137.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2022	2024	CCG	141;141;141	C,G;C,G;GCCC,GCCCCC	103,2;107,1;97,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5458	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3034	179.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1606	1608	CCG	204;207;210	C;C;G	183;194;196	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2084	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1843	112.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	565	565	C	133	C	118	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	S271T	NONSYN	811	813	TCG	49	51	ACT	50;51;50	A;C;T	28;29;29	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	55	57	GAT	38;38;35	G;A;T	29;30;30	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	D276N	NONSYN	826	828	GAT	64	66	AAC	37;37;37	A;A;C	32;31;31	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	N277H	NONSYN	829	831	AAC	67	69	CAC	37;37;37	C;A;C	31;32;31	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	R307E	NONSYN	919	921	AGA	157	159	GAA	14;14;14	G;A;A	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	169	171	GCA	12;12;12	G;C;A	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	E312D	NONSYN	934	936	GAA	172	174	GAC	12;12;12	G;A;C	12;11;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	178	180	ATC	12;12;12	A;T;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	184	186	TCG	11;11;11	T;C;G	11;11;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	190	192	GCC	12;12;12	G;C;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	193	195	AGC	12;12;12	A;G;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	196	198	GCC	12;12;12	G;C;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	260	porB1a	984	222	90.99	porB1a.l6.c30.ctg.3	333	20.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	202	204	GTT	11;11;11	G;T;T	10;10;11	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2734	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1752	154.8	1	SNP	p	G120K	1	.	.	358	360	AAG	803	805	AAG	238;236;237	A;A;G	228;225;222	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2734	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1752	154.8	1	SNP	p	A121N	1	.	.	361	363	AAC	806	808	AAC	234;231;231	A;A;C	222;218;222	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2734	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1752	154.8	1	SNP	p	N121D	0	.	.	361	363	AAC	806	808	AAC	234;231;231	A;A;C	222;218;222	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	S217G	NONSYN	649	651	AGC	176	178	GGC	7;7;7	G;G;C	7;7;7	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	D222N	NONSYN	664	666	GAT	191	193	AAT	7;7;7	A;A;T	7;7;7	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	V230A	NONSYN	688	690	GTA	215	217	GCA	10;10;10	G;C;A	10;10;10	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	V238Y	NONSYN	712	714	GTT	239	241	TAT	12;13;14	T;A;T	12;13;14	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	.	INDELS	715	717	GAA	243	249	GAGCAAT	15;15;15;16;16;19;19	G;A;G;C;A;A;T	15;15;15;16;16;19;19	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	.	INDELS	719	720	AC	252	254	GCG	25;25;24	G;C;G	25;25;24	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	L253V	NONSYN	757	759	TTG	293	295	GTA	44;44;44	G;T;A	39;39;39	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	S273T	NONSYN	817	819	TCG	353	355	ACT	53;54;53	A;C;T	45;46;45	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	K278N	NONSYN	832	834	AAA	368	370	AAC	42;42;44	A;A;C	38;37;39	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	R279H	NONSYN	835	837	CGC	371	373	CAC	47;50;50	C;A;C	42;46;45	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	E313A	NONSYN	937	939	GAA	473	475	GCA	45;42;40	G;C;A	41;38;38	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	N314D	NONSYN	940	942	AAC	476	478	GAC	39;39;37	G;A;C	38;38;36	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	314	porB3	990	315	90.12	porB3.l15.c30.ctg.1	485	28.4	0	.	p	.	0	F316I	NONSYN	946	948	TTC	482	484	ATC	29;25;24	A;T;C	28;23;9	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10730	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4843	221.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1114	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1138	97.6	1	SNP	p	V57M	1	.	.	169	171	ATG	632	634	ATG	229;226;227	A,G;T;G	214,1;211;213	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
